ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352741 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352741; 2) Community: the network communities that were significantly associated with the response to NSC 352741; 3) Molecule: the relationships between components within communities and NSC 352741; 4) MDR: the compounds that were significantly associated with the NSC 352741.

NSC Compound Enrichment Correlation
NSC 749147 Null 0.0102077332082017 0.3314195
NSC 100071 component of Halotex 0.0102962192514438 0.31593727
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0102962192514438 -0.06250881
NSC 176503 Fastigilin B 0.0102962192514438 0.45489427
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0102962192514438 0.44035382
NSC 46683 Null 0.0102962192514439 0.36672927
NSC 615552 Null 0.0102962192514439 0.36818239
NSC 620687 Null 0.0102962192514439 0.45148711
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.0102962192514439 0.37358838
NSC 628115 9-N(N'-chloroethyl-N'-methyl-1,2-diaminoethyl) 2 methoxyacridine dihydrochloride 0.0102962192514439 0.4216416
Total:89  Current:18    [First] [Prev] [Next] [Last]